Delhi HC directs Sun Pharma to take permission before launching semaglutide
Steady2 outlets reported this in 2 reports over 2 days
Tue, 11 August 2026Sat, 15 August 2026
What it is about
Amit SibalJustice Anup BhambaniSun PharmaNovo NordiskCentral Drugs Standard Control OrganisationExpert CommitteeDelhi, Delhi, IndiaIndiaMumbai, Maharashtra, IndiaDrugs Control AdministrationTelangana, Andhra Pradesh, India
Who published it, and when
original reportfirst to report
livemint.com
webindia123.com
11 Aug, 14:29over 4 days15 Aug, 11:27
How it spread - 2 original reports
Tue, 11 August 2026
1 report- livemint.com14:29first to report
Delhi High Court ordered Sun Pharma to seek judicial approval before launching semaglutide tablets, following a patent infringement suit by Novo Nordisk. The order requires Sun Pharma to return to court once it secures a manufacturing licence.
Sat, 15 August 2026
1 report- webindia123.com11:27